Successful treatment of aortic endocarditis by Achromobacter xylosoxidans with cefiderocol combination therapy in a non-Hodgkin lymphoma patient: case report and literature review
Gianfranco La Bella , Francesco Salvato , Graziano Antonio Minafra , Irene Francesca Bottalico
Antibiotics 11 ( 12) 1686 -1686
6
2022
In vitro activity of ceftazidime/avibactam against carbapenem-nonsusceptible Klebsiella penumoniae isolates collected during the first wave of the SARS-CoV-2 pandemic: a Southern Italy, multicenter, surveillance study
Gianfranco La Bella , Teresa Lopizzo , Laura Lupo , Rosa Angarano
Journal of Global Antimicrobial Resistance 31 236 -238
3
2022
Results of an universal screening for SARS-CoV-2 in women admitted for delivery in a geographical area with low incidence of COVID-19 infection
Felice Sorrentino , MARIANTONIETTA DI STEFANO , Giuseppina Faleo , Fabio Arena
Journal of Preventive Medicine and Hygiene 62 ( 2) E296 -E296
2021
Method for detecting gut microorganism in a sample using normal gut flora as internal control
Lee Hyeon-Ji , Oh Myung-Suk , Giani Tommaso , Fabio Arena
2019
Impiego di macrolidi nell’area senese e chemioresistenze in Streptococcus pyogenes
Francesca Montagnani , Lucia Stolzuoli , Leonardo Croci , Fabio Arena
2007
Ruolo della fast microbiology nell’era dei patogeni MDR
Fabio Arena
Percorsi clinici 42 -42
Minerva Biotechnology and Biomolecular Research 2022 March; 34 (1): 47
Jose R FIORE , Mariantonietta DI STEFANO , R LIPSI Maria , Francescopaolo ANTONUCCI
Minerva 34
2022
2017
Epidemic diffusion of KPC carbapenemase-producing Klebsiella pneumoniae in Italy: results of the first countrywide survey, 15 May to 30 June 2011.
G M Rossolini , G M Rossolini , F Luzzaro , A Pantosti
Eurosurveillance 18 ( 22) 20489 -20489
126
2013
Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014.
M. Monaco , T Giani , M Raffone , F Arena
Eurosurveillance 19 ( 42) 14 -18
221
2014
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study
A Lasagna , F Agustoni , E Percivalle , S Borgetto
ESMO open 6 ( 5) 100272
25
2021
Network EuSCAPE-Italy, Grundmann H, Pantosti A, Rossolini GM. 2014. Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014
M Monaco , T Giani , M Raffone , F Arena
Euro Surveill 19 ( 42) 14 -18
52
AMCLICRE Survey Participants, Pantosti A, Pagani L, Luzzaro F, Rossolini GM. 2013. Epidemic diffusion of KPC carbapenemase-producing Klebsiella pneumoniae in Italy: results of the first countrywide survey, 15 May to 30 June 2011
T Giani , B Pini , F Arena , V Conte
Euro Surveill 18 20489 -20489
34
2013
Differential features of the two clades of ST258 KPC-producing Klebsiella pneumoniae caused by different expression of the Mrk fimbrial system.
F Arena , G Landini , A Cannatelli , M D’Andrea
2016
Enterobacteriaceae producing ESBLs, AmpCs and carbapenemases emerging among outpatients, Italy
F Luzzaro , C Mauri , T Giani , Roberta Migliavacca
2014
Rapid strategy to detect colonisation by KCP-producing Klebsiella pneumoniae during an outbreak
C Tascini , F Menichetti , T Giani , F Arena
CLINICAL MICROBIOLOGY AND INFECTION 17 ( s4) 155 -156
2011
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study
A Lasagna , F Bergami , D Lilleri , E Percivalle
ESMO open 7 ( 2) 100458 -100458
21
2022
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up
A Lasagna , D Lilleri , F Agustoni , E Percivalle
ESMO open 7 ( 1) 100359 -100359
18
2022
Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment
A Lasagna , F Bergami , D Lilleri , E Percivalle
Annals of Oncology 33 ( 11) 1207 -1208
5
2022
CARBAPENEM-RESISTANT ENTEROBACTERIACEAE INFECTIONS IN HEMATOLOGIC PATIENTS: RESULTS OF A PROSPECTIVE SURVEILLANCE PROGRAM
R Fanci , P Pecile , F Arena , B Scappini
HAEMATOLOGICA 100 67 -68
2015